Diquafosol Tetrasodium

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2003-2017
02420032017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
PURPOSE To evaluate the effectiveness of 3% diquafosol tetrasodium for treating dry eye after cataract surgery. METHODS Among… (More)
Is this relevant?
2015
2015
PURPOSE This study was undertaken to determine the effect of topical application of diquafosol tetrasodium on proteins and mucin… (More)
Is this relevant?
2014
2014
PURPOSE To evaluate the effect of diquafosol tetrasodium (DQS) for the treatment of persistent dry eye after laser in situ… (More)
Is this relevant?
2014
2014
PURPOSE To evaluate the possible advantages of combination therapy with diquafosol tetrasodium and sodium hyaluronate for dry eye… (More)
Is this relevant?
Review
2014
Review
2014
INTRODUCTION Dry eye is a multifactorial disease of the ocular surface causing ocular discomfort and visual impairment for the… (More)
Is this relevant?
2013
2013
PURPOSE To investigate the effect of diquafosol tetrasodium on tear and visual function in short break-up time (sBUT) dry eye (DE… (More)
Is this relevant?
2012
2012
PurposeTo assess the additive effect of diquafosol tetrasodium on sodium hyaluronate monotherapy in patients with dry eye… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2004
2004
PURPOSE To investigate the safety and efficacy of diquafosol tetrasodium, a P2Y2 receptor agonist that stimulates fluid and mucin… (More)
Is this relevant?
Review
2004
Review
2004
The ophthalmic formulation of diquafosol tetrasodium (INS365), a P2Y2 receptor agonist, is targeted to treat dry eye disease… (More)
Is this relevant?
Review
2003
Review
2003
Inspire, in collaboration with Allergan and Santen, is developing an eye-drop formulation of diquafosol tetrasodium (INS-365), a… (More)
Is this relevant?